eli lilly and company news - Search News

The Motley Fool on MSN · 3d

With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second. Demand for Eli Lilly's Mounjaro and Zepbound remains robust, and sell-side analysts tracking script data shows strong growth for both of these drugs.

Business Insider · 20h

Eli Lilly & Co: Buy Rating Justified Despite Short-Term Sales Miss

Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target

24/7 Wall St. on MSN · 4d

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 568.82% and currently trading at $884.25. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,

Hosted on MSN · 5d

Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Momentum Stock Now

Business Insider · 5d

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

In a report released today, Carter Gould from Barclays maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a

Michigan Attorney General Fights to Revoke Decades-Old Rulings Shielding Pharma Giant Eli Lilly from Insulin Pricing Scrutiny

Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...

22hon MSN

Novo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

1d

Eli Lilly and Company (NYSE:LLY) Shares Up 2.3% – Here’s What Happened

Eli Lilly and Company (NYSE:LLY – Get Free Report) shares rose 2.3% on Tuesday . The company traded as high as $920.28 and ...

1d

AG, Eli Lilly spar before the Michigan Supreme Court over insulin pricing investigation

The justices are considering an effort challenging longstanding case law blocking the state’s ability to probe inflated drug ...

1d

Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves

Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...

22h

Eli Lilly and Company (NYSE:LLY) Shares Sold by Sanibel Captiva Trust Company Inc.

Sanibel Captiva Trust Company Inc. lowered its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8% ...

4don MSN

Billion-Dollar News for Eli Lilly Stock Investors

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

1d

Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

Eli Lilly, Insitro ink a new kind of AI drug development deal

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...

8d

Eli Lilly announces $4.5 billion research and manufacturing facility in Lebanon LEAP district

Scheduled to open in late 2027, the site will combine research and manufacturing and increase the company's investment in the ...

FierceBiotech4d

AstraZeneca pays CSPC $100M for preclinical heart disease drug, teeing up combos and Lilly rivalry

AstraZeneca has paid CSPC Pharmaceutical Group $100 million for a preclinical cardiovascular disease drug candidate. The deal ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results